Showing results (11-20 of 128) with videos related to
Sort By:
Pageof 13
Oncotarget|December 22, 2016
Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanesEmily Kolyvas, Michael Rudloff, Marianne Poruchynsky, et al.Cytometry. Part B, Clinical Cytometry|July 28, 2012
Flow cytometry increases the sensitivity of detection of leukemia and lymphoma cells in bronchoalveolar lavage specimensJoo Y Song, Armando C Filie, David Venzon, et al.Journal of Virology|July 22, 2016
Relationship between Vaccine-Induced Antibody Capture of Infectious Virus and Infection Outcomes following Repeated Low-Dose Rectal Challenges with Simian Immunodeficiency Virus SIVmac251Johannes S Gach, David Venzon, Monica Vaccari, et al.Mucosal Immunology|June 3, 2018
Influence of gut microbiome on mucosal immune activation and SHIV viral transmission in naive macaquesYongjun Sui, Amiran Dzutsev, David Venzon, et al.Plos One|October 22, 2013
Effects of the deletion of early region 4 (E4) open reading frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on virus-host cell interaction, transgene expression, and immunogenicity of replicating adenovirus HIV vaccine vectorsMichael A Thomas, Rui Song, Thorsten Demberg, et al.Urology|August 11, 2004
Risk factors for skin breakdown after renal and adrenal surgeryJennifer Stevens, Erika Nichelson, W Marston Linehan, et al.Virology|July 8, 2015
Loss of marginal zone B-cells in SHIVSF162P4 challenged rhesus macaques despite control of viremia to low or undetectable levels in chronic infectionThorsten Demberg, Venkatramanan Mohanram, Thomas Musich, et al.Journal of Neuro-Oncology|October 12, 2013
Measurements of the pons as a biomarker of progression for pediatric DIPGEmilie A Steffen-Smith, Eva H Baker, David Venzon, et al.AJR. American Journal of Roentgenology|January 5, 2002
Sonography and MR imaging of posterior tibial tendinopathyAhalya Premkumar, Monique B Perry, Andrew J Dwyer, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2006
Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancerJessica M Faupel-Badger, Sheila A Prindiville, David Venzon, et al.Pageof 13